Lumateperonedosage
lumateperone 21 MG Oral Capsule [Caplyta]
Dosage and administration
Recommended oral dosage of CAPLYTA is 42 mg once daily with or without food. Moderate hepatic impairment or severe hepatic impairment: Recommended dosage is 21 mg once daily.
2.1 Recommended
Dosage The recommended CAPLYTA dosage is 42 mg administered orally once daily with or without food. Dose titration is not needed.
2.2 Dosage Recommendations for
Concomitant Use with Moderate or Strong CYP3A4 Inhibitors The recommended CAPLYTA dosage in patients who receive: Strong CYP3A4 inhibitors is 10.5 mg once daily. Moderate CYP3A4 inhibitors is 21 mg once daily.
2.3 Dosage Recommendations for
Patients with Hepatic Impairment For patients with moderate hepatic impairment (HI) (Child-Pugh class B) or severe HI (Child-Pugh class C), the recommended CAPLYTA dosage is 21 mg once daily. The recommended CAPLYTA dosage in patients with mild HI is the same as those with normal hepatic function.
Text above is quoted in full from the FDA-approved drug label published by openFDA, effective June 20, 2025. Matched to this product by RxNorm code. Cross-references to other sections of the full prescribing information have been removed, since they point to a document not shown here. Nothing else is changed: no sentence is shortened, reworded or summarised.
This page reproduces regulatory text for reference. It is not medical advice, and KenyRx is not a pharmacy or a prescriber. Talk to a doctor or pharmacist about whether a medicine is right for you.
See what it costs — price without insurance